- Andrey Kondratovich
- About company
- On November 1st, Andrey Kondratovich, our friend and associate, COO of our company, passed away.
This is a huge and terrible loss for us as professionals, an irreparable personal loss. Andrey was a wonderful, tactful person, a perfect leader and an excellent professional. He put all his heart into the building of HemaCore trying to implement there his own vision of an ideal company; this is what he was building together with all of us, working for up to 14 hours per day.
Andrey was a pure soul, a perfectly decent person. The more is the pity to realize that he is no more with us.
We will always remember him.
We will continue developing HemaCore the way Andrew would like to see him. A company trying to implement something that seems impossible to the majority of people, a company changing medicine for the better, a company seeking to help the doctors save thousands of human lives. While each saved person is as necessary and dear to someone as Andrey was dear and necessary to us. To save even one human life for those who care and love is a decent mission.
Our heartfelt condolences go to the Andrey's family.
HemaCore is a biotech company, develops medical devices and methods for hematology. HemaCore was founded in April, 2010 by a group of scientist who invented and patented the Thrombodynamics – a new global assay for monitoring and prognosis of blood coagulation disorders: bleeding and thrombosis, precursors of heart attacks and strokes. In 2010 HemaCore received the first round of investments from RUSNANO and Sberbank Capital intended for developing the analyser, consumables and organization of clinical trials in Russia. HemaCore has completed final design of product for the serial production of the Thrombodynamics analyzer and disposables. In Europe and USA: Research Use Only.
- 25 November 2014 Company news
- 29 May 2014 Company news
- 13 January 2014 Company news